Tekla Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-58,241
Closed -$2.75M 215
2019
Q3
$2.75M Buy
58,241
+51,941
+824% +$2.37M 0.12% 118
2019
Q2
$297K Hold
6,300
0.01% 189
2019
Q1
$303K Hold
6,300
0.01% 186
2018
Q4
$281K Hold
6,300
0.01% 195
2018
Q3
$340K Hold
6,300
0.01% 203
2018
Q2
$308K Hold
6,300
0.01% 174
2018
Q1
$395K Hold
6,300
0.02% 179
2017
Q4
$386K Sell
6,300
-70,300
-92% -$4.35M 0.01% 156
2017
Q3
$5.13M Hold
76,600
0.18% 91
2017
Q2
$5.97M Hold
76,600
0.22% 80
2017
Q1
$6.25M Sell
76,600
-75,900
-50% -$5.97M 0.24% 75
2016
Q4
$11M Hold
152,500
0.47% 50
2016
Q3
$11.8M Buy
+152,500
New +$12.3M 0.46% 51

Other funds holding CAH

Tekla Capital Management's CAH Position: Q4 2019 in Review

Tekla Capital Management sold out of Cardinal Health (CAH) in Q4 2019, closing a stake of 58,241 shares — an estimated $2.75M sold.

Tekla Capital Management first reported a position in CAH in Q3 2016 and held it in 13 quarters. The position peaked at $11.8M in Q3 2016. 713 funds tracked by Wall St. Rank hold CAH as of Q4 2019.

  • Tekla Capital Management reported no remaining Cardinal Health position as of Q4 2019 after selling out during the quarter.
  • Tekla Capital Management sold 58,241 Cardinal Health shares in Q4 2019, an estimated $2.75M.
  • Tekla Capital Management first reported a position in Cardinal Health in Q3 2016 and held it in 13 quarters.
  • Tekla Capital Management's Cardinal Health position peaked at $11.8M in Q3 2016.
  • 713 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2019.

Based on Tekla Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.